We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report CIS - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Jun 11, 2024

CIS - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

CIS: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in CIS

In 2023, after two years of decline, there was significant growth in overseas shipments of medicaments containing insulin but not antibiotics in measured doses, when their volume increased by X% to X tons. In general, exports posted a resilient increase. The pace of growth was the most pronounced in 2020 with an increase of X%. The volume of export peaked at X tons in 2018; however, from 2019 to 2023, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2023. Overall, exports saw a noticeable increase. The pace of growth appeared the most rapid in 2020 with an increase of X%. The level of export peaked at $X in 2018; however, from 2019 to 2023, the exports remained at a lower figure.

Exports by Country

Russia dominates exports structure, recording X tons, which was approx. X% of total exports in 2023. Belarus (X kg) followed a long way behind the leaders.

Russia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of X% from 2012 to 2023. Belarus (X%) illustrated a downward trend over the same period. From 2012 to 2023, the share of Russia increased by X percentage points.

In value terms, Russia ($X) remains the largest prophylactic medicaments containing insulin supplier in the CIS, comprising X% of total exports. The second position in the ranking was taken by Belarus ($X), with a X% share of total exports.

From 2012 to 2023, the average annual growth rate of value in Russia stood at X%.

Export Prices by Country

In 2023, the export price in the CIS amounted to $X per ton, with a decrease of X% against the previous year. Overall, the export price saw a deep reduction. The most prominent rate of growth was recorded in 2020 when the export price increased by X%. As a result, the export price reached the peak level of $X per ton. From 2021 to 2023, the export prices failed to regain momentum.

Average prices varied somewhat amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Belarus ($X per ton), while Russia stood at $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Russia (X%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in CIS

In 2023, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses was finally on the rise to reach X tons for the first time since 2018, thus ending a four-year declining trend. Overall, imports posted a temperate increase. The growth pace was the most rapid in 2013 when imports increased by X%. Over the period under review, imports hit record highs at X tons in 2018; however, from 2019 to 2023, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports rose to $X in 2023. Over the period under review, imports, however, showed a deep setback. The pace of growth appeared the most rapid in 2018 with an increase of X% against the previous year. The level of import peaked at $X in 2013; however, from 2014 to 2023, imports failed to regain momentum.

Imports by Country

In 2023, Russia (X tons), distantly followed by Uzbekistan (X tons), Kazakhstan (X tons), Azerbaijan (X tons) and Kyrgyzstan (X tons) represented the major importers of medicaments containing insulin but not antibiotics in measured doses, together creating X% of total imports. Belarus (X tons) and Moldova (X tons) held a minor share of total imports.

From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main importing countries, was attained by Azerbaijan (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Russia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in the CIS, comprising X% of total imports. The second position in the ranking was held by Kazakhstan ($X), with a X% share of total imports. It was followed by Uzbekistan, with a X% share.

From 2012 to 2023, the average annual growth rate of value in Russia totaled X%. In the other countries, the average annual rates were as follows: Kazakhstan (X% per year) and Uzbekistan (X% per year).

Import Prices by Country

In 2023, the import price in the CIS amounted to $X per ton, which is down by X% against the previous year. Over the period under review, the import price faced a deep contraction. The growth pace was the most rapid in 2018 when the import price increased by X%. Over the period under review, import prices hit record highs at $X per ton in 2012; however, from 2013 to 2023, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Russia ($X per ton), while Uzbekistan ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Azerbaijan (X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in CIS. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Production in CIS, split by region and country
  • Trade (exports and imports) in CIS
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY

  8. 8. IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • Armenia
    • Azerbaijan
    • Belarus
    • Kazakhstan
    • Kyrgyzstan
    • Moldova
    • Russia
    • Tajikistan
    • Uzbekistan

  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023

  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023

Recommended reports

Asia - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 399

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.

U.S. - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 355

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..

China - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 347

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.

EU - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 384

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.

World - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
$599
Jun 11, 2024
Eye 454

This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.

Free Data: Medicaments Containing Insulin But Not Antibiotics In Measured Doses - CIS
Table
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - CIS - Table
Dashboard
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - CIS - Dashboard
Report
Medicaments Containing Insulin But Not Antibiotics In Measured Doses - CIS - Report